Emily Vittetoe is a Iowa City, Iowa based nurse practitioner. Active license number of Emily Vittetoe is A181855 for Family in Iowa. Her current practice location is 200 Hawkins Dr, Iowa City. Patients can reach her at 319-356-3689 or can fax her at 319-353-6343 and her NPI number (Unique professional ID assigned by NPPES) is 1811717564. Emily Vittetoe has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Emily Vittetoe speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1811717564
NPI Enumeration Date:
16 Oct, 2024
NPI Last Update On:
06 Dec, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Vittetoe are as mentioned below.
License Number
Specialization
State
Status
A181855
Family
Iowa
Primary
155342
Registered Nurse
Iowa
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Emily Vittetoe 200 Hawkins Dr, Iowa City, Iowa
Zip:
52242-1009
Phone Number:
319-356-3689
Fax Number:
319-353-6343
Patients can reach Emily Vittetoe at 200 Hawkins Dr, Iowa City, Iowa or can call to book an appointment on 319-356-3689.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 February, 2025.